Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M K Samson

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Cancer Chemotherapy Reports|November 1, 1975
Phase I study of 5-azacytidine (NSC-102816) using 24-hour continuous infusion for 5 daysP L Lomen, L H Baker, G L Neil, et al.
Investigational New Drugs|May 1, 1993
Evaluation of amonafide in disseminated malignant melanoma. A Southwest Oncology Group studyM Slavik, K J Kopecky, V Sondak, et al.
Cancer Treatment Reports|November 1, 1979
Cis-dichlorodiammineplatinum(II) in advanced soft tissue and bony sarcomas: a Southwest Oncology Group StudyM K Samson, L H Baker, R S Benjamin, et al.
Cancer Treatment Reports|October 1, 1986
Cisplatin and etoposide before definitive radiation therapy for inoperable squamous carcinoma, adenocarcinoma, and large cell carcinoma of the lung: a phase I-II study of the Radiation Therapy Oncology GroupJ D Cox, M K Samson, A M Herskovic, et al.
Michigan Medicine|November 1, 1975
Granulocyte transfusions collected from normal donorsT Buroker, M Lefevre, M K Samson, et al.
American Journal of Clinical Oncology|August 1, 1985
Phase II evaluation of aclacinomycin-A in patients with adenocarcinoma and large cell carcinoma of the lungE Tapazoglou, C D Haas, M K Samson, et al.
Cancer Treatment Reports|July 1, 1981
Phase II study of AMSA in lung cancerM K Samson, R J Fraile, L H Baker, et al.
Cancer Treatment Reports|August 1, 1978
Phase I--II study of intermittent bolus administration of DTIC and actinomycin D in metastatic malignant melanomaM K Samson, L H Baker, R W Talley, et al.
Cancer Treatment Reports|November 1, 1977
5-FU infusion and cyclophosphamide in the treatment of advanced ovarian cancerR M Izbicki, L H Baker, M K Samson, et al.
American Journal of Clinical Oncology|October 1, 1983
Combination chemotherapy with mitomycin C, adriamycin, and cyclophosphamide (MAC) in stage III and IV ovarian cancerV Ratanatharathorn, M K Samson, L H Baker, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Cancer Chemotherapy Reports|November 1, 1975
Phase I study of 5-azacytidine (NSC-102816) using 24-hour continuous infusion for 5 daysP L Lomen, L H Baker, G L Neil, et al.
Investigational New Drugs|May 1, 1993
Evaluation of amonafide in disseminated malignant melanoma. A Southwest Oncology Group studyM Slavik, K J Kopecky, V Sondak, et al.
Cancer Treatment Reports|November 1, 1979
Cis-dichlorodiammineplatinum(II) in advanced soft tissue and bony sarcomas: a Southwest Oncology Group StudyM K Samson, L H Baker, R S Benjamin, et al.
Cancer Treatment Reports|October 1, 1986
Cisplatin and etoposide before definitive radiation therapy for inoperable squamous carcinoma, adenocarcinoma, and large cell carcinoma of the lung: a phase I-II study of the Radiation Therapy Oncology GroupJ D Cox, M K Samson, A M Herskovic, et al.
Michigan Medicine|November 1, 1975
Granulocyte transfusions collected from normal donorsT Buroker, M Lefevre, M K Samson, et al.
American Journal of Clinical Oncology|August 1, 1985
Phase II evaluation of aclacinomycin-A in patients with adenocarcinoma and large cell carcinoma of the lungE Tapazoglou, C D Haas, M K Samson, et al.
Cancer Treatment Reports|July 1, 1981
Phase II study of AMSA in lung cancerM K Samson, R J Fraile, L H Baker, et al.
Cancer Treatment Reports|August 1, 1978
Phase I--II study of intermittent bolus administration of DTIC and actinomycin D in metastatic malignant melanomaM K Samson, L H Baker, R W Talley, et al.
Cancer Treatment Reports|November 1, 1977
5-FU infusion and cyclophosphamide in the treatment of advanced ovarian cancerR M Izbicki, L H Baker, M K Samson, et al.
American Journal of Clinical Oncology|October 1, 1983
Combination chemotherapy with mitomycin C, adriamycin, and cyclophosphamide (MAC) in stage III and IV ovarian cancerV Ratanatharathorn, M K Samson, L H Baker, et al.
Pageof 6